ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 145168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 145168; 2) Community: the network communities that were significantly associated with the response to NSC 145168; 3) Molecule: the relationships between components within communities and NSC 145168; 4) MDR: the compounds that were significantly associated with the NSC 145168.

NSC Compound Enrichment Correlation
NSC 608329 Null 0.0209467683758286 0.10120573
NSC 617394 Null 0.0209467683758286 0.38334928
NSC 641454 3'-O-(Dimethylaminoethylcarbonyl)-(Z)-combretastatin A-4 0.0209467683758286 0.1660009
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0209467683758286 0.70972155
NSC 67041 Null 0.0209467683758286 0.22936146
NSC 671765 3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione 0.0209467683758286 0.21534826
NSC 672058 Null 0.0209467683758286 0.69179139
NSC 677784 Null 0.0209467683758286 0.25246734
NSC 678869 Benz[a]anthracene-6,6-dicarboxylic acid, 5,6,7,12- tetrahydro-2-methoxy-7,12-dioxo-, dimethyl ester 0.0209467683758286 0.36406062
NSC 681632 Camptothecin Derivative 0.0209467683758286 0.094424274
Total:94  Current:52    [First] [Prev] [Next] [Last]